Grant: Planning and Dissemination Grant - Institute Community Support
University of Guelph
$20,000.00
The 2026 New Antibacterial Discovery and Development Gordon Research Conference: A Catalyst for Translational Research
FY 2025-26
Summary
The 2026 Gordon Research Conference (GRC) on New Antibacterial Discovery and Development (NADD) and its accompanying Gordon Research Seminar aim to address the urgent need for new, effective antibacterial therapies. Antimicrobial resistance (AMR) threatens to render current antibiotics ineffective, resulting in untreatable infections, prolonged hospital stays, and increased mortality.
The 2026 GRC on NADD will unite basic science and drug development. This interdisciplinary platform will foster collaboration on discovering the next generation of safe, effective antibiotics: tomorrow's antibacterials. This year's conference will emphasize the global scale of AMR, highlighting unmet clinical needs and solutions. Key sessions will showcase new and promising drugs in the clinical pipeline, highlight advancements at the preclinical stage, and introduce innovative approaches and technologies transforming antibacterial discovery and development. By convening experts from various sectors, the NADD GRC continues to serve as a catalyst for progress in the fight against AMR, promoting interdisciplinary collaboration and the advancement of effective antibacterial therapies. Emphasis will be placed on creating networking opportunities for early-career researchers and trainees, enabling them to build connections, gain valuable insights, and advance their professional growth in the field of NADD.
This conference is pivotal for advancing antibacterial research and development, aligning directly with the CIHR AMR Research Initiative's focus on fostering broader engagement and innovative solutions to combat AMR. The participation of individuals from Canadian institutions will ensure that students, postdocs, and early-career investigators gain essential knowledge and networks to drive impactful innovation, while industry involvement will provide crucial insights into translating research findings into practical applications.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
531087
Name
Cox Georgina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
The 2026 New Antibacterial Discovery and Development Gordon Research Conference: A Catalyst for Translational Research
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Guelph
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Antimicrobial Resistance; Drug Development; Drug Discovery; Infection And Immunity; Knowledge Translation; Microbiology
Abstract
The 2026 Gordon Research Conference (GRC) on New Antibacterial Discovery and Development (NADD) and its accompanying Gordon Research Seminar aim to address the urgent need for new, effective antibacterial therapies. Antimicrobial resistance (AMR) threatens to render current antibiotics ineffective, resulting in untreatable infections, prolonged hospital stays, and increased mortality.
The 2026 GRC on NADD will unite basic science and drug development. This interdisciplinary platform will foster collaboration on discovering the next generation of safe, effective antibiotics: tomorrow's antibacterials. This year's conference will emphasize the global scale of AMR, highlighting unmet clinical needs and solutions. Key sessions will showcase new and promising drugs in the clinical pipeline, highlight advancements at the preclinical stage, and introduce innovative approaches and technologies transforming antibacterial discovery and development. By convening experts from various sectors, the NADD GRC continues to serve as a catalyst for progress in the fight against AMR, promoting interdisciplinary collaboration and the advancement of effective antibacterial therapies. Emphasis will be placed on creating networking opportunities for early-career researchers and trainees, enabling them to build connections, gain valuable insights, and advance their professional growth in the field of NADD.
This conference is pivotal for advancing antibacterial research and development, aligning directly with the CIHR AMR Research Initiative's focus on fostering broader engagement and innovative solutions to combat AMR. The participation of individuals from Canadian institutions will ensure that students, postdocs, and early-career investigators gain essential knowledge and networks to drive impactful innovation, while industry involvement will provide crucial insights into translating research findings into practical applications.
Competitiondate
202506
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cox, Georgina
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~